NDC Package 69866-2002-3 Nexobrid

Anacaulase-bcdb Kit Topical - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
69866-2002-3
Package Description:
1 KIT in 1 CARTON * 2 g in 1 VIAL, GLASS (69866-2000-1) * 20 g in 1 JAR (69866-2001-2)
Product Code:
Proprietary Name:
Nexobrid
Non-Proprietary Name:
Anacaulase-bcdb
Usage Information:
NEXOBRID is indicated for eschar removal in adults with deep partial thickness (DPT) and/or full thickness (FT) thermal burns.Limitations of UseThe safety and effectiveness of NEXOBRID have not been established for treatment of:Chemical or electrical burnsBurns on the face, perineum, or genitaliaBurns on the feet of patients with diabetes mellitus or on the feet of patients with occlusive vascular diseaseCircumferential burnsBurns in patients with significant cardiopulmonary disease, including inhalation injuryNEXOBRID is not recommended for wounds contaminated with radioactive and other hazardous substances to avoid unforeseeable reactions with the product and an increased risk of spreading the noxious substance.
11-Digit NDC Billing Format:
69866200203
NDC to RxNorm Crosswalk:
  • RxCUI: 2626751 - anacaulase-bcdb 8.8 % Topical Gel, 22 GM
  • RxCUI: 2626751 - 22000 MG anacaulase-bcdb 0.088 MG/MG Topical Gel
  • RxCUI: 2626754 - NexoBrid 8.8 % Topical Gel, 22 GM
  • RxCUI: 2626754 - 22000 MG anacaulase-bcdb 0.088 MG/MG Topical Gel [Nexobrid]
  • RxCUI: 2626754 - 22000 MG Nexobrid 0.088 MG/MG Topical Gel
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Vericel Corporation
    Dosage Form:
    Kit - A packaged collection of related material.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Sample Package:
    No
    FDA Application Number:
    BLA761192
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    12-29-2022
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 69866-2002-3?

    The NDC Packaged Code 69866-2002-3 is assigned to a package of 1 kit in 1 carton * 2 g in 1 vial, glass (69866-2000-1) * 20 g in 1 jar (69866-2001-2) of Nexobrid, a human prescription drug labeled by Vericel Corporation. The product's dosage form is kit and is administered via topical form.

    Is NDC 69866-2002 included in the NDC Directory?

    Yes, Nexobrid with product code 69866-2002 is active and included in the NDC Directory. The product was first marketed by Vericel Corporation on December 29, 2022 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 69866-2002-3?

    The 11-digit format is 69866200203. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-169866-2002-35-4-269866-2002-03